Biotech Values

[dav1234]

U.K.'s Lombard looks to join U.S. biotech party
Lombard Medical Technologies plans to delist in London and carry out an $80M IPO on Nasdaq, where it intends to trade under the ticker symbol "EVAR."
Lombard has yet to decide how many shares it will offer, nor at what price.
The U.K. medical-devices company, which focus on the repair of aneurysms, intends to use the proceeds from the offering to increase its U.S. sales force and to develop products.
http://online.wsj.com/article/PR-CO-20140311-902096.html